Personal tools

Coexpression cluster:C4073: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Coexpression_clusters
{
|full_id=C4073_splenic_cord_adult_hairy_spleen_Multipotent_Burkitt
 

Latest revision as of 12:38, 17 September 2013


Full id: C4073_splenic_cord_adult_hairy_spleen_Multipotent_Burkitt



Phase1 CAGE Peaks

Hg19::chr21:27794750..27794757,+p@chr21:27794750..27794757
+
Hg19::chr2:111562736..111562747,+p3@ACOXL
Hg19::chr8:42623674..42623685,-p3@CHRNA6


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0003997acyl-CoA oxidase activity0.0191762526007121
GO:0005892nicotinic acetylcholine-gated receptor-channel complex0.0191762526007121
GO:0016634oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor0.0191762526007121
GO:0015464acetylcholine receptor activity0.0191762526007121
GO:0042166acetylcholine binding0.0191762526007121
GO:0004889nicotinic acetylcholine-activated cation-selective channel activity0.0191762526007121
GO:0003995acyl-CoA dehydrogenase activity0.02357974527894
GO:0043176amine binding0.0275052468288009
GO:0005231excitatory extracellular ligand-gated ion channel activity0.0389860458602887
GO:0016627oxidoreductase activity, acting on the CH-CH group of donors0.0389860458602887
GO:0042579microbody0.0389860458602887
GO:0005777peroxisome0.0389860458602887
GO:0043235receptor complex0.0389860458602887
GO:0050660FAD binding0.0389860458602887
GO:0005230extracellular ligand-gated ion channel activity0.0389860458602887
GO:0030594neurotransmitter receptor activity0.0389860458602887
GO:0042165neurotransmitter binding0.0389860458602887
GO:0045211postsynaptic membrane0.0389860458602887
GO:0044456synapse part0.0389860458602887
GO:0015276ligand-gated ion channel activity0.0389860458602887
GO:0022834ligand-gated channel activity0.0389860458602887
GO:0006631fatty acid metabolic process0.0433233753343024



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
umbilical cord1.28e-1410
blastocyst1.28e-1410
blastula1.28e-1410
bilaminar disc1.28e-1410
inner cell mass1.28e-1410
cleaving embryo1.28e-1410
connecting stalk1.28e-1410
inner cell mass derived epiblast1.28e-1410
extraembryonic mesoderm1.28e-1410
blood6.02e-1015
haemolymphatic fluid6.02e-1015
organism substance6.02e-1015
Disease
Ontology termp-valuen
lymphoma3.22e-3810
anemia1.21e-161
non-Hodgkin lymphoma1.41e-161
cutaneous T cell lymphoma1.41e-161
mycosis fungoides1.41e-161
hematologic cancer1.30e-1051
immune system cancer1.30e-1051
hematopoietic system disease5.49e-092


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.10.0471418
MA0004.10.826076
MA0006.10.639288
MA0007.10.804807
MA0009.11.3275
MA0014.10.118426
MA0017.10.686276
MA0019.10.990656
MA0024.11.21731
MA0025.11.46617
MA0027.12.95767
MA0028.10.658629
MA0029.11.23771
MA0030.11.22561
MA0031.11.15713
MA0038.10.94098
MA0040.11.24388
MA0041.10.847069
MA0042.10.810843
MA0043.11.32783
MA0046.11.31611
MA0048.10.341392
MA0050.10.81185
MA0051.10.936307
MA0052.11.24796
MA0055.10.557638
MA0056.10
MA0057.10.333427
MA0058.10.716037
MA0059.10.714521
MA0060.10.492218
MA0061.12.01615
MA0063.10
MA0066.10.941452
MA0067.11.65513
MA0068.11.04561
MA0069.11.31207
MA0070.11.30033
MA0071.10.897953
MA0072.11.29561
MA0073.10.211629
MA0074.10.935474
MA0076.10.734647
MA0077.11.28751
MA0078.11.04495
MA0081.10.714712
MA0083.11.33535
MA0084.11.84562
MA0087.11.29304
MA0088.10.715722
MA0089.10
MA0090.10.751469
MA0091.10.829044
MA0092.10.785956
MA0093.10.642957
MA0095.10
MA0098.10
MA0100.10.956299
MA0101.10.646932
MA0103.10.628063
MA0105.11.5295
MA0106.10.986396
MA0107.11.36919
MA0108.21.15387
MA0109.10
MA0111.10.767139
MA0113.11.00436
MA0114.11.35563
MA0115.11.57693
MA0116.10.560723
MA0117.11.36676
MA0119.10.695578
MA0122.11.39371
MA0124.11.53432
MA0125.11.44766
MA0130.10
MA0131.11.06461
MA0132.10
MA0133.10
MA0135.11.35921
MA0136.10.948776
MA0139.10.440097
MA0140.10.894983
MA0141.10.712476
MA0142.11.12317
MA0143.11.00455
MA0144.10.531867
MA0145.10.273764
MA0146.10.107247
MA0147.10.565108
MA0148.10.854239
MA0149.10.884158
MA0062.20.449458
MA0035.20.894194
MA0039.20.195278
MA0138.21.04628
MA0002.20.476938
MA0137.20.666381
MA0104.20.491226
MA0047.20.973066
MA0112.20.264678
MA0065.20.277623
MA0150.10.744617
MA0151.10
MA0152.10.902317
MA0153.11.43021
MA0154.10.312019
MA0155.10.711948
MA0156.10.669101
MA0157.11.09377
MA0158.10
MA0159.10.565904
MA0160.10.871361
MA0161.10
MA0162.10.149099
MA0163.10.122425
MA0164.11.01792
MA0080.20.643061
MA0018.20.987913
MA0099.22.08754
MA0079.20.0107199
MA0102.21.88331
MA0258.10.519674
MA0259.10.575594
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.